HLN-601
N/A
Report date: 2024/02/26 16:10:53
NME
Base Information
Drug NameHLN-601
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of SciencesBohai Rim Advanced Research Institute for Drug DiscoveryYantai Institute of Materia Medica
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesHongliang (Shanghai) Biomedical Technology Co LtdBohai Rim Advanced Research Institute for Drug DiscoveryYantai Institute of Materia Medica +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A